Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase <scp>III</scp> randomised clinical trial

Authors

И. Е. Макаренко (ORCID: https://orcid.org/0000-0003-2308-0608)
Anna Arefeva (ORCID: https://orcid.org/0000-0003-3178-3581)
Iuliia Matvienko (ORCID: https://orcid.org/0000-0002-3655-1707)
Р. В. Драй (ORCID: https://orcid.org/0000-0003-4594-6097)
G. R. Galstyan (ORCID: https://orcid.org/0000-0001-6581-4521)
Т. Л. Каронова (ORCID: https://orcid.org/0000-0002-1547-0123)
Dmitrii Iliushchenko (ORCID: https://orcid.org/0000-0003-3875-2024)
Tatyana Parfenova (ORCID: https://orcid.org/0000-0002-1140-6722)
Ekaterina Protsenko (ORCID: https://orcid.org/0000-0003-4341-2884)

Institutions

ITMO University (RU)
Federal Almazov North-West Medical Research Centre (RU)
Endocrinology Research Center (RU)
Krasnoyarsk State Medical University (RU)
Chemopharma (Austria) (AT)

Publication Details

Journal: Diabetes Obesity and Metabolism
Published: 2025-12-09
DOI: https://doi.org/10.1111/dom.70360
Primary Topic: Diabetes and associated disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial

И. Е. Макаренко, Anna Arefeva, Iuliia Matvienko, Р. В. Драй et al.

Dec 9, 2025

Diabetes Obesity and Metabolism

Diabetes and associated disorders

article

Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial

И. Е. Макаренко, Anna Arefeva, Iuliia Matvienko, Р. В. Драй, G. R. Galstyan, Т. Л. Каронова, Dmitrii Iliushchenko, Tatyana Parfenova, Ekaterina Protsenko

December 9, 2025article en

Abstract

No abstract available for this paper.

Diabetes Obesity and MetabolismVol. 28(3)

ITMO University (RU), Federal Almazov North-West Medical Research Centre (RU), Endocrinology Research Center (RU), Krasnoyarsk State Medical University (RU), Chemopharma (Austria) (AT)

Openalex Percentile: Top 59%

Diabetes and associated disorders

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase <scp>III</scp> randomised clinical trial — И. Е. Макаренко, Anna Arefeva, et al. · Diabetes Obesity and Metabolism (2025) | TGRS Research Map | TGRS